MCM
CRL icon

Monument Capital Management’s Charles River Laboratories CRL Stock Holding History

Monument Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-150
Closed -$20K – 146
2018
Q3 		$20K Buy
+150
New +$18.5K 0.01% 160

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Monument Capital Management's CRL Position: Q4 2018 in Review

Monument Capital Management sold out of Charles River Laboratories (CRL) in Q4 2018, closing a stake of 150 shares — an estimated $20K sold.

Monument Capital Management first reported a position in CRL in Q3 2018 and held it in 1 quarter. The position peaked at $20K in Q3 2018. 407 funds tracked by Wall St. Rank hold CRL as of Q4 2018.

  • Monument Capital Management reported no remaining Charles River Laboratories position as of Q4 2018 after selling out during the quarter.
  • Monument Capital Management sold 150 Charles River Laboratories shares in Q4 2018, an estimated $20K.
  • Monument Capital Management first reported a position in Charles River Laboratories in Q3 2018 and held it in 1 quarter.
  • Monument Capital Management's Charles River Laboratories position peaked at $20K in Q3 2018.
  • 407 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2018.

Based on Monument Capital Management's 13F filing for Q4 2018, filed 15 Jan 2019.